Biomark Diagnostics Statistics

Total Valuation

CSE:BUX has a market cap or net worth of CAD 57.23 million. The enterprise value is 56.65 million.

Market Cap	57.23M
Enterprise Value	56.65M

Important Dates

The next estimated earnings date is Wednesday, July 29, 2026.

Earnings Date	Jul 29, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	105.09M
Shares Outstanding	n/a
Shares Change (YoY)	-84.66%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	12.50%
Owned by Institutions (%)	n/a
Float	48.27M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	623.56
PB Ratio	112.64
P/TBV Ratio	112.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-33.33
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-27.63

Financial Position

The company has a current ratio of 1.20, with a Debt / Equity ratio of 1.40.

Current Ratio	1.20
Quick Ratio	1.20
Debt / Equity	1.40
Debt / EBITDA	n/a
Debt / FCF	-0.35
Interest Coverage	-39.96

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-81.70%
Return on Invested Capital (ROIC)	-152.63%
Return on Capital Employed (ROCE)	-218.42%
Weighted Average Cost of Capital (WACC)	2.92%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +132.00% in the last 52 weeks. The beta is -0.25, so CSE:BUX's price volatility has been lower than the market average.

Beta (5Y)	-0.25
52-Week Price Change	+132.00%
50-Day Moving Average	0.58
200-Day Moving Average	0.42
Relative Strength Index (RSI)	48.62
Average Volume (20 Days)	5,600

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CSE:BUX had revenue of CAD 91,771 and -1.70 million in losses. Loss per share was -0.02.

Revenue	91,771
Gross Profit	91,771
Operating Income	-1.97M
Pretax Income	-1.70M
Net Income	-1.70M
EBITDA	-1.95M
EBIT	-1.97M
Loss Per Share	-0.02

Balance Sheet

The company has 1.29 million in cash and 711,779 in debt, giving a net cash position of 574,407.

Cash & Cash Equivalents	1.29M
Total Debt	711,779
Net Cash	574,407
Net Cash Per Share	n/a
Equity (Book Value)	508,033
Book Value Per Share	0.00
Working Capital	243,539

Cash Flow

In the last 12 months, operating cash flow was -1.42 million and capital expenditures -629,165, giving a free cash flow of -2.05 million.

Operating Cash Flow	-1.42M
Capital Expenditures	-629,165
Depreciation & Amortization	15,956
Net Borrowing	340,392
Free Cash Flow	-2.05M
FCF Per Share	n/a

Margins

Gross Margin	100.00%
Operating Margin	-2,145.47%
Pretax Margin	-1,852.06%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CSE:BUX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	84.66%
Shareholder Yield	84.66%
Earnings Yield	-2.97%
FCF Yield	-3.58%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CSE:BUX has an Altman Z-Score of -3.64 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.64
Piotroski F-Score	2